Preclinical Ophthalmology · Tel Aviv

Advanced therapies for the eye.

Aurora Pharmaceuticals is a physician-founded biotechnology company based in Tel Aviv, Israel.

Get in touch About Aurora

Under the microscopeA slice through the iris.

Melanocytes

PrecisionDesigned to reach the cells that matter.

CareAnd checked for safety at every step.

About

The eye is among the most delicate organs we have. It deserves medicines made with equal care.

Aurora was founded in 2023 to develop a new medicine for the eye. The program is at the preclinical stage, run by a small team with specialist research partners and senior advisers.

Approach

Built on three commitments.

01 · Precision

Designed for
selective delivery.

Our research focuses on reaching the cells that matter, and on measuring exposure elsewhere in the eye.

Stage
Pre­clinical

One focused program, advancing step by step.

02 · Safety first

Measured at every stage.

Imaging, tissue analysis and eye examinations.

03 · Rigor
Expert reviewExperimental validationTraceable evidence

Evidence guides each decision.

Base

Tel Aviv, Israel.

Working with research partners in Israel and the United States.

Company

On the record.

Legal name
Aurora Pharmaceuticals Ltd.
Incorporated
January 2023
Headquarters
Tel Aviv, Israel
Field
Ophthalmology
Stage
Preclinical
Contact

Let's talk.

For research collaborations, partnerships and investor enquiries, write to our founder.

ran@aurora.icu

Ran Greenberg, MD · Founder & CEO